NCT02686099 (SL360) is a NA clinical trial of SternaLock 360 in Sternal Fracture, sponsored by Zimmer Biomet.

Who is sponsoring NCT02686099?

NCT02686099 is sponsored by Zimmer Biomet.

What drugs are being tested in NCT02686099?

Interventions in NCT02686099: SternaLock 360, Wire Cerclage.

What condition does NCT02686099 study?

NCT02686099 studies Sternal Fracture.

Is NCT02686099 still recruiting?

NCT02686099 is currently completed. Last updated 18 January 2018.

Last reviewed 2018-01-18 · How we verify

NCT02686099: SL360

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sternal Closure With SternaLock 360: First in Man Study

Completed NA Last updated 18 January 2018

What this trial tests

NA trial testing SternaLock 360 in Sternal Fracture in 50 participants. Completed in 15 January 2018.

Timeline

4 July 2015

Primary endpoint
5 September 2017

15 January 2018

Quick facts

Lead sponsor	Zimmer Biomet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	4 July 2015
Primary completion	5 September 2017
Estimated completion	15 January 2018
Sites	1 location across South Africa

Drugs / interventions tested

SternaLock 360
Wire Cerclage

Conditions studied

Sternal Fracture — all drugs for Sternal Fracture →

Sponsor

Zimmer Biomet — full company profile →

Who can join

30 and older, any sex, with Sternal Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The SternaLock 360 Sternal Closure Device combines the techniques of rigid fixation with a cerclage material into a single sternal closure system. The cerclage material serves to facilitate sternal approximation, and the plates and screws serve to provide rigid fixation and prevent sternal movement and separation. The combination of a cerclage material in combination with plate and screw fixation may also lead to increased stability compared to either method used as a standalone means of closure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Zimmer Biomet trials

Trials by the same sponsor.

NCT06287853 — Tapestry Rotator Cuff Repair PMCF · suspended
NCT06863428 — Mymobility Knee ROM · recruiting
NCT06920459 — Zimmer Biomet Shoulder Arthroplasty PMCF Study · recruiting
NCT07009912 — ROSA® Knee System V1.5 Pilot Study · NA · completed
NCT06615739 — Comprehensive SRS Regenerex Tissue Attachment · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02686099 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zimmer Biomet
Last refreshed: 18 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02686099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing